| Product Code: ETC9961235 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Brain Disease Imaging and Software Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Brain Disease Imaging and Software Market - Industry Life Cycle |
3.4 United States (US) Brain Disease Imaging and Software Market - Porter's Five Forces |
3.5 United States (US) Brain Disease Imaging and Software Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Brain Disease Imaging and Software Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Brain Disease Imaging and Software Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 United States (US) Brain Disease Imaging and Software Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Brain Disease Imaging and Software Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of brain disorders and diseases in the United States |
4.2.2 Technological advancements in brain imaging and software solutions |
4.2.3 Growing awareness and focus on early detection and diagnosis of brain diseases |
4.3 Market Restraints |
4.3.1 High costs associated with brain imaging equipment and software solutions |
4.3.2 Stringent regulatory requirements for approval of brain imaging technologies |
4.3.3 Limited access to advanced brain imaging technologies in certain regions of the United States |
5 United States (US) Brain Disease Imaging and Software Market Trends |
6 United States (US) Brain Disease Imaging and Software Market, By Types |
6.1 United States (US) Brain Disease Imaging and Software Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Imaging Devices, 2021- 2031F |
6.1.4 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Software, 2021- 2031F |
6.2 United States (US) Brain Disease Imaging and Software Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.3 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Dementia, 2021- 2031F |
6.2.4 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Stroke, 2021- 2031F |
6.2.5 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.6 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.7 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Brain Tumors, 2021- 2031F |
6.2.8 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.2.9 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.3 United States (US) Brain Disease Imaging and Software Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Adults, 2021- 2031F |
6.3.3 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Pediatrics, 2021- 2031F |
6.3.4 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Infants, 2021- 2031F |
6.4 United States (US) Brain Disease Imaging and Software Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Ambulatory Surgery Centers, 2021- 2031F |
6.4.4 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
6.4.5 United States (US) Brain Disease Imaging and Software Market Revenues & Volume, By Research Institutions, 2021- 2031F |
7 United States (US) Brain Disease Imaging and Software Market Import-Export Trade Statistics |
7.1 United States (US) Brain Disease Imaging and Software Market Export to Major Countries |
7.2 United States (US) Brain Disease Imaging and Software Market Imports from Major Countries |
8 United States (US) Brain Disease Imaging and Software Market Key Performance Indicators |
8.1 Adoption rate of advanced brain imaging technologies in healthcare facilities |
8.2 Number of research studies and clinical trials utilizing brain imaging and software solutions |
8.3 Percentage of healthcare professionals trained in the use of brain imaging technologies |
9 United States (US) Brain Disease Imaging and Software Market - Opportunity Assessment |
9.1 United States (US) Brain Disease Imaging and Software Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Brain Disease Imaging and Software Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Brain Disease Imaging and Software Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 United States (US) Brain Disease Imaging and Software Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Brain Disease Imaging and Software Market - Competitive Landscape |
10.1 United States (US) Brain Disease Imaging and Software Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Brain Disease Imaging and Software Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here